Dr. Yi-Kong Keung, MD

Dr. Keung practices at Alhambra Surgery Center, LLC in Alhambra, California.

Dr. Keung's NPI, 1326023482, was assigned on December 13, 2005. Dr. Keung graduated from University of Hong Kong Faculty of Medicine in 1985. Dr. Keung holds California license C53429.

Dr. Keung's primary practice is Alhambra Surgery Center, LLC, at 707 S Garfield Ave, Alhambra, CA 91801 in Los Angeles County. The practice phone is (626) 656-1285.

Dr. Keung's primary practice is Alhambra Surgery Center, LLC in Alhambra, California. Dr. Keung is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Keung to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keung practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Keung's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Keung's licenses on file in 4 states: California, North Carolina, Texas and Washington.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Keung treats.

CMS data shows 1,137 Medicare services from Dr. Keung across 10 procedure codes in 2024, for 223 Medicare patients. Medicare paid $56,798 for them.

CMS counts 223 Medicare patients who saw Dr. Keung in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 62% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keung's median patient age at 67, with 53% women.

In 2024, Dr. Keung wrote 374 Medicare Part D claims for 65 patients. 59% of them were for generic drugs. CMS names the drug for 159 of them, across 9 drugs with 11 or more claims each, at $724,095 in total drug cost. In 2023, CMS named 232 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Keung for performance year 2024, reported as part of a group. Dr. Keung accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 72 papers to Dr. Keung, published from 2009 to 2019. The most frequent topics are Bone Marrow Transplantation, Karyotyping and Translocation, Genetic. Dr. Keung has published most often in Cancer Genet Cytogenet. Dr. Keung's most frequent co-authors are Everardo Cobos, MD, Dan Douer, MD and Eddie Hong-Lung Hu, MD.

CMS Open Payments shows 8 general payments to Dr. Keung from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Agios Pharmaceuticals, Inc. paid the most, $140.

Dmand AI lists 1 award for Dr. Keung, most recently CMS Stage 1 2012 in 2011.

Dr. Keung graduated from University of Hong Kong Faculty of Medicine in 1985.

Dr. Keung is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.